In this study, we evaluated the effects of FGFC1 on NSCLC cells both in vitro and in vivo and determined the inhibitory property of FGFC1 on the NF-κB pathway in NSCLC cells for the first time. This evidence concerns the gene NFKB1 and non-small cell lung carcinoma.